{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:50:52Z","timestamp":1789051852898,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003121"],"award-info":[{"award-number":["82003121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82460134"],"award-info":[{"award-number":["82460134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20242BAB20409"],"award-info":[{"award-number":["20242BAB20409"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB206021"],"award-info":[{"award-number":["20232BAB206021"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25552-w","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:47:08Z","timestamp":1763988428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["OLR1 is closely related to poor prognosis and immune cell infiltration in gastric cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Meixia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaofeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"3","key":"25552_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J. Clin. 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA: Cancer J. Clin."},{"issue":"5","key":"25552_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2020-322065","volume":"70","author":"JBY So","year":"2021","unstructured":"So, J. B. Y. et al. Development and validation of a serum microrna biomarker panel for detecting gastric cancer in a high-risk population. Gut 70(5), 829\u2013837. https:\/\/doi.org\/10.1136\/gutjnl-2020-322065 (2021).","journal-title":"Gut"},{"issue":"2","key":"25552_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00464-017-5730-7","volume":"32","author":"M Inokuchi","year":"2018","unstructured":"Inokuchi, M. et al. Long- and short-term outcomes of laparoscopic gastrectomy versus open gastrectomy in patients with clinically and pathological locally advanced gastric cancer: A propensity-score matching analysis. Surg. Endosc. 32(2), 735\u2013742. https:\/\/doi.org\/10.1007\/s00464-017-5730-7 (2018).","journal-title":"Surg. Endosc."},{"issue":"1","key":"25552_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0163-7258(02)00236-x","volume":"95","author":"M Chen","year":"2002","unstructured":"Chen, M., Masaki, T. & Sawamura, T. Lox-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: Implications in endothelial dysfunction and atherosclerosis. Pharmacol. Ther. 95(1), 89\u2013100. https:\/\/doi.org\/10.1016\/s0163-7258(02)00236-x (2002).","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"25552_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1158\/1541-7786.Mcr-19-0718","volume":"18","author":"G Yang","year":"2020","unstructured":"Yang, G. et al. Olr1 promotes pancreatic cancer metastasis via increased C-Myc expression and transcription of Hmga2. Mol. Cancer Res. MCR 18(5), 685\u2013697. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-19-0718 (2020).","journal-title":"Mol. Cancer Res. MCR"},{"issue":"Pt B","key":"25552_CR6","doi-asserted-by":"publisher","first-page":"108275","DOI":"10.1016\/j.intimp.2021.108275","volume":"101","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Olr1 is a prognostic factor and correlated with immune infiltration in breast cancer. Int. Immunopharmacol. 101(Pt B), 108275. https:\/\/doi.org\/10.1016\/j.intimp.2021.108275 (2021).","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"25552_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12935-024-03436-9","volume":"24","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. Prrx1-Olr1 axis supports Cafs-mediated lung cancer progression and immune suppression. Cancer Cell Int. 24(1), 247. https:\/\/doi.org\/10.1186\/s12935-024-03436-9 (2024).","journal-title":"Cancer Cell Int."},{"issue":"8","key":"25552_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41571-021-00492-2","volume":"18","author":"Y Nakamura","year":"2021","unstructured":"Nakamura, Y., Kawazoe, A., Lordick, F., Janjigian, Y. Y. & Shitara, K. Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm. Nat. Rev. Clin. Oncol. 18(8), 473\u2013487. https:\/\/doi.org\/10.1038\/s41571-021-00492-2 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6382","key":"25552_CR9","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359(6382), 1350\u20131355. https:\/\/doi.org\/10.1126\/science.aar4060 (2018).","journal-title":"Science"},{"issue":"3","key":"25552_CR10","doi-asserted-by":"publisher","first-page":"106214","DOI":"10.1016\/j.isci.2023.106214","volume":"26","author":"J Shi","year":"2023","unstructured":"Shi, J. et al. Characterization of glycometabolism and tumor immune microenvironment for predicting clinical outcomes in gastric cancer. iScience 26(3), 106214. https:\/\/doi.org\/10.1016\/j.isci.2023.106214 (2023).","journal-title":"iScience"},{"issue":"6","key":"25552_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoncol.2021.0275","volume":"7","author":"J Chao","year":"2021","unstructured":"Chao, J. et al. Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the keynote-059, keynote-061, and keynote-062 clinical trials. JAMA Oncol. 7(6), 895\u2013902. https:\/\/doi.org\/10.1001\/jamaoncol.2021.0275 (2021).","journal-title":"JAMA Oncol."},{"issue":"5","key":"25552_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.20132","volume":"62","author":"JM Kirkwood","year":"2012","unstructured":"Kirkwood, J. M. et al. Immunotherapy of cancer in 2012. CA: Cancer J. Clin. 62(5), 309\u2013335. https:\/\/doi.org\/10.3322\/caac.20132 (2012).","journal-title":"CA: Cancer J. Clin."},{"issue":"2","key":"25552_CR13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.4049\/jimmunol.177.2.1052","volume":"177","author":"JJ Engelhardt","year":"2006","unstructured":"Engelhardt, J. J., Sullivan, T. J. & Allison, J. P. Ctla-4 overexpression inhibits T Cell responses through a Cd28-B7-dependent mechanism. J Immunol 177(2), 1052\u20131061. https:\/\/doi.org\/10.4049\/jimmunol.177.2.1052 (2006).","journal-title":"J Immunol"},{"key":"25552_CR14","doi-asserted-by":"publisher","unstructured":"Expansion of the gene ontology knowledgebase and resources. Nucleic Acids Res. 45(D1), D331\u2013d8. https:\/\/doi.org\/10.1093\/nar\/gkw1108. (2017).","DOI":"10.1093\/nar\/gkw1108"},{"issue":"D1","key":"25552_CR15","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"25552_CR16","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"25552_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"25552_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7. https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","journal-title":"BMC Bioinform."},{"issue":"4","key":"25552_CR19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39(4), 782\u2013795. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.003 (2013).","journal-title":"Immunity"},{"issue":"2","key":"25552_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173(2), 400\u201316.e11. https:\/\/doi.org\/10.1016\/j.cell.2018.02.052 (2018).","journal-title":"Cell"},{"issue":"11","key":"25552_CR21","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1158\/0008-5472.Can-20-3779","volume":"81","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. N(6) -methyladenosine regulates mRNA stability and translation efficiency of KRT7 to promote breast cancer lung metastasis. Cancer Res. 81(11), 2847\u20132860. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-3779 (2021).","journal-title":"Cancer Res."},{"issue":"5\u20136","key":"25552_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10495-023-01931-4","volume":"29","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Panoptosis subtypes predict prognosis and immune efficacy in gastric cancer. Apoptosis: Int. J Program. Cell Death 29(5\u20136), 799\u2013815. https:\/\/doi.org\/10.1007\/s10495-023-01931-4 (2024).","journal-title":"Apoptosis: Int. J Program. Cell Death"},{"issue":"1","key":"25552_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/1440-1681.13401","volume":"48","author":"PB Wang","year":"2021","unstructured":"Wang, P. B., Chen, Y., Ding, G. R., Du, H. W. & Fan, H. Y. Keratin 18 induces proliferation, migration, and invasion in gastric cancer via the MAPK signalling Pathway. Clin. Exp. Pharmacol. Physiol. 48(1), 147\u2013156. https:\/\/doi.org\/10.1111\/1440-1681.13401 (2021).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"25552_CR24","doi-asserted-by":"publisher","first-page":"641322","DOI":"10.3389\/fmicb.2021.641322","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang, J., Zhou, X., Liu, X., Ling, Z. & Ji, F. Role of the gastric microbiome in gastric cancer: From carcinogenesis to treatment. Front. Microbiol. 12, 641322. https:\/\/doi.org\/10.3389\/fmicb.2021.641322 (2021).","journal-title":"Front. Microbiol."},{"issue":"1","key":"25552_CR25","doi-asserted-by":"publisher","first-page":"e0077221","DOI":"10.1128\/msphere.00772-21","volume":"7","author":"Z Shen","year":"2022","unstructured":"Shen, Z. et al. Gastric non-helicobacter pylori urease-positive Staphylococcus Epidermidis and Streptococcus salivarius Isolated from Humans Have Contrasting Effects on H. Pylori-associated gastric pathology and host immune responses in a Murine model of gastric cancer. mSphere 7(1), e0077221. https:\/\/doi.org\/10.1128\/msphere.00772-21 (2022).","journal-title":"mSphere"},{"issue":"7","key":"25552_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda, T. & Wang, Y. A. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends Cancer 10(7), 627\u2013642. https:\/\/doi.org\/10.1016\/j.trecan.2024.03.008 (2024).","journal-title":"Trends Cancer"},{"issue":"11","key":"25552_CR27","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19(11), 1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394 (2013).","journal-title":"Nat. Med."},{"issue":"5","key":"25552_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (Time) for effective therapy. Nat. Med. 24(5), 541\u2013550. https:\/\/doi.org\/10.1038\/s41591-018-0014-x (2018).","journal-title":"Nat. Med."},{"issue":"1","key":"25552_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/21655979.2020.1864912","volume":"12","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Analysis of collagen type X Alpha 1 (Col10a1) expression and prognostic significance in gastric cancer based on bioinformatics. Bioengineered 12(1), 127\u2013137. https:\/\/doi.org\/10.1080\/21655979.2020.1864912 (2021).","journal-title":"Bioengineered"},{"issue":"4","key":"25552_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.tibtech.2015.01.004","volume":"33","author":"R Malik","year":"2015","unstructured":"Malik, R., Lelkes, P. I. & Cukierman, E. Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer. Trends Biotechnol. 33(4), 230\u2013236. https:\/\/doi.org\/10.1016\/j.tibtech.2015.01.004 (2015).","journal-title":"Trends Biotechnol."},{"issue":"2","key":"25552_CR31","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/0008-5472.Can-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis, C. E. & Pollard, J. W. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66(2), 605\u2013612. https:\/\/doi.org\/10.1158\/0008-5472.Can-05-4005 (2006).","journal-title":"Cancer Res."},{"issue":"7","key":"25552_CR32","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/ni1477","volume":"8","author":"M Hirano","year":"2007","unstructured":"Hirano, M. et al. Igeb Immune complexes activate macrophages through FcgammaRIV binding. Nat. Immunol. 8(7), 762\u2013771. https:\/\/doi.org\/10.1038\/ni1477 (2007).","journal-title":"Nat. Immunol."},{"issue":"10","key":"25552_CR33","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.4049\/jimmunol.1303375","volume":"193","author":"A Dom\u00ednguez-Soto","year":"2014","unstructured":"Dom\u00ednguez-Soto, A. et al. Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization. J. Immunol. 193(10), 5181\u20135189. https:\/\/doi.org\/10.4049\/jimmunol.1303375 (2014).","journal-title":"J. Immunol."},{"issue":"4","key":"25552_CR34","doi-asserted-by":"publisher","first-page":"e20240445","DOI":"10.1084\/jem.20240445","volume":"222","author":"SN Tan","year":"2025","unstructured":"Tan, S. N. et al. Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39. J. Exp. Med. 222(4), e20240445. https:\/\/doi.org\/10.1084\/jem.20240445 (2025).","journal-title":"J. Exp. Med."},{"issue":"22","key":"25552_CR35","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.jacc.2017.04.010","volume":"69","author":"NVK Pothineni","year":"2017","unstructured":"Pothineni, N. V. K. et al. Lox-1 in atherosclerosis and myocardial ischemia: Biology, genetics, and modulation. J. Am. Coll. Cardiol. 69(22), 2759\u20132768. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.010 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"25552_CR36","doi-asserted-by":"publisher","first-page":"12904","DOI":"10.3390\/ijms241612904","volume":"24","author":"L Wu","year":"2023","unstructured":"Wu, L. et al. OLR1 is a pan-cancer prognostic and immunotherapeutic predictor associated with EMT and Cuproptosis in HNSCC. Int. J. Mol. Sci. 24(16), 12904. https:\/\/doi.org\/10.3390\/ijms241612904 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"25552_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41419-021-04174-w","volume":"13","author":"T Zhao","year":"2021","unstructured":"Zhao, T., Li, Y., Shen, K., Wang, Q. & Zhang, J. Knockdown of OLR1 weakens glycolytic metabolism to repress colon cancer cell proliferation and chemoresistance by downregulating SULT2B1 via c-MYC. Cell Death Dis. 13(1), 4. https:\/\/doi.org\/10.1038\/s41419-021-04174-w (2021).","journal-title":"Cell Death Dis."},{"issue":"5","key":"25552_CR38","doi-asserted-by":"publisher","first-page":"e20277","DOI":"10.1371\/journal.pone.0020277","volume":"6","author":"M Khaidakov","year":"2011","unstructured":"Khaidakov, M. et al. Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer. PLoS ONE 6(5), e20277. https:\/\/doi.org\/10.1371\/journal.pone.0020277 (2011).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25552-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T01:03:22Z","timestamp":1764378202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25552-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25552"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25552-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6509290\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41611"}}